English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  51504470    在线人数 :  794
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"jia horng kao"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 486-510 / 1180 (共48页)
<< < 15 16 17 18 19 20 21 22 23 24 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2021-09-04T06:11:21Z Can noninvasive biomarkers replace liver biopsy for chronic hepatitis B? Lin C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:20Z Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model Li Y.-T.; Liu C.-J.; Su T.-H.; Cheng H.-R.; Jeng Y.-M.; Lin H.-L.; Wang C.-C.; JIA-HORNG KAO; Chen P.-J.; Chen D.-S.; Wu H.-L.
臺大學術典藏 2021-09-04T06:11:20Z Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis Yang H.-I.; Tseng T.-C.; Liu J.; Lee M.-H.; Liu C.-J.; Su T.-H.; Batrla-Utermann R.; Chan H.L.Y.; JIA-HORNG KAO; Chen C.-J.
臺大學術典藏 2021-09-04T06:11:19Z HIV/HCV coinfection in Taiwan Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:19Z Hepatocellular carcinoma recurrence after interferon-free direct acting antiviral treatment for chronic hepatitis C virus infection: Fact or fiction? Liu C.-H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:19Z New perspectives of biomarkers for the management of chronic hepatitis B Lin C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:19Z Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update Sarin S.K.; Kumar M.; Lau G.K.; Abbas Z.; Chan H.L.Y.; Chen C.J.; Chen D.S.; Chen H.L.; Chen P.J.; Chien R.N.; Dokmeci A.K.; Gane E.; Hou J.L.; Jafri W.; Jia J.; Kim J.H.; Lai C.L.; Lee H.C.; Lim S.G.; Liu C.J.; Locarnini S.; Al Mahtab M.; Mohamed R.; Omata M.; Park J.; Piratvisuth T.; Sharma B.C.; Sollano J.; Wang F.S.; Wei L.; Yuen M.F.; Zheng S.S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:18Z Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan Wang C.-C.; Lin C.-L.; Hsieh T.-Y.; Tseng K.-C.; Peng C.-Y.; Su T.-H.; Yang S.-S.; Hsu Y.-C.; Chen T.-M.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:18Z Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study Su T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; Chen C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:18Z Hepatitis C virus infection in Taiwan: Past, present, and future JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:17Z Faldaprevir, pegylated interferon, and ribavirin for treatment-na?ve HCV genotype-1: Pooled analysis of two phase 3 trials Jensen D.M.; Asselah T.; Dieterich D.; Foster G.R.; Sulkowski M.S.; Zeuzem S.; Mantry P.; Yoshida E.M.; Moreno C.; Ouzan D.; Wright M.; Morano L.E.; Buynak R.; Bourli?re M.; Hassanein T.; Nishiguchi S.; JIA-HORNG KAO; Omata M.; Paik S.W.; Wong D.K.; Tam E.; Kaita K.; Victor Feinman S.; Stern J.O.; Scherer J.; Quinson A.-M.; Voss F.; Gallivan J.-P.; B?cher W.O.; Ferenci P.
臺大學術典藏 2021-09-04T06:11:17Z Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection Yang W.-T.; Wu L.-W.; Tseng T.-C.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Liu C.-J.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:17Z Daclatasvir-containing all-oral regimens for the treatment of hepatitis C virus infection Yang S.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:16Z How have the recent advances in antiviral therapy impacted the management of virus-related hepatocellular carcinoma? Wang C.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:16Z Perspectives on dual hepatitis B and C infection in Taiwan Liu C.-J.; Chen P.-J.; Chen D.-S.; Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:15Z Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis JIA-HORNG KAO; Jensen D.M.; Manns M.P.; Jacobson I.; Kumada H.; Toyota J.; Heo J.; Yoffe B.; Sievert W.; Bessone F.; Peng C.-Y.; Roberts S.K.; Lee Y.-J.; Bhore R.; Mendez P.; Hughes E.; Noviello S.
臺大學術典藏 2021-09-04T06:11:15Z Management of hepatitis C patients with decompensated liver disease Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:15Z Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues Tseng K.-C.; Tseng C.-W.; Hsieh T.-Y.; Peng C.-Y.; Lin C.-L.; Su T.-H.; Tseng T.-C.; Lin H.H.; Wang C.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:14Z A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection JIA-HORNG KAO; Chien R.-N.; Chang T.-T.; Peng C.-Y.; Hu T.-H.; Lo G.-H.; Wang H.-Y.; Chen J.-J.; Yang J.C.; Knox S.J.; Han L.; Mo H.; Mathias A.; Brainard D.M.; Sheen I.-S.; Hsu Y.-C.; Chu C.-J.; Chuang W.-L.
臺大學術典藏 2021-09-04T06:11:14Z Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus Chuang W.-L.; Chien R.-N.; Peng C.-Y.; Chang T.-T.; Lo G.-H.; Sheen I.-S.; Wang H.-Y.; Chen J.-J.; Yang J.C.; Knox S.J.; Gao B.; Garrison K.L.; Mo H.; Pang P.S.; Hsu Y.-C.; Hu T.-H.; Chu C.-J.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:14Z Review article: novel therapies for hepatitis B virus cure – advances and perspectives Lin C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:13Z Assessing the Durability of Entecavir-Treated Hepatitis B Using Quantitative HBsAg Wang C.-C.; Tseng K.-C.; Hsieh T.-Y.; Tseng T.-C.; Lin H.H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:13Z Association of SCARB1 Gene Polymorphisms with Virological Response in Chronic Hepatitis C Patients Receiving Pegylated Interferon plus Ribavirin Therapy Hsu C.-S.; Hsu S.-J.; Liu W.-L.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:13Z Liver gene expression profiles correlate with virus infection and response to interferon therapy in chronic hepatitis B patients Wu H.-L.; Hsiao T.-H.; Chen P.-J.; Wong S.-H.; JIA-HORNG KAO; Chen D.-S.; Lu J.-Y.; Lu T.-P.; Chen Y.; Chuang E.Y.; Tu H.-C.; Liu C.-J.
臺大學術典藏 2021-09-04T06:11:12Z APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing Omata M.; Kanda T.; Wei L.; Yu M.-L.; Chuang W.-L.; Ibrahim A.; Lesmana C.R.A.; Sollano J.; Kumar M.; Jindal A.; Sharma B.C.; Hamid S.S.; Dokmeci A.K.; Al-Mahtab M.; McCaughan G.W.; Wasim J.; Crawford D.H.G.; JIA-HORNG KAO; Yokosuka O.; Lau G.K.K.; Sarin S.K.

显示项目 486-510 / 1180 (共48页)
<< < 15 16 17 18 19 20 21 22 23 24 > >>
每页显示[10|25|50]项目